Bolt Projects Files S-1 for $20M Equity Line Amidst Mounting Losses

TL;DR

**Bolt's S-1 screams desperation for cash, with the $20M equity line a temporary fix that will likely dilute shareholders further as losses mount and delisting looms.**

AI Summary

Bolt Projects Holdings, Inc. (BSLKW) filed an S-1 on September 26, 2025, to register up to 20,085,588 shares of common stock for resale by Ascent Partners Fund LLC. This includes 20,000,000 Purchase Shares under an Equity Line of Credit (ELOC) facility, allowing Bolt to sell up to $20.0 million of common stock to Ascent, and 85,588 Commitment Shares issued to Ascent for its commitment. Bolt will not receive proceeds from Ascent's resale but may receive up to $20.0 million from direct sales to Ascent under the ELOC. The company reported a net loss of $65.4 million for the year ended December 31, 2024, and $10.5 million for the six months ended June 30, 2025, with an accumulated deficit of $472.3 million as of June 30, 2025. Bolt has strategically shifted to focus solely on its Vegan Silk Technology Platform, discontinuing other product candidates in early 2023. The common stock trades on Nasdaq under 'BSLK', closing at $3.96 per share on September 25, 2025. The company faces significant risks, including a history of losses, negative cash flows, and potential Nasdaq delisting if an appeal is unsuccessful.

Why It Matters

This S-1 filing reveals Bolt Projects Holdings' critical need for capital, highlighted by its $472.3 million accumulated deficit and ongoing net losses, including $10.5 million in H1 2025. The $20.0 million equity line of credit with Ascent Partners Fund LLC is a lifeline, but the continuous dilution from potential stock sales by Ascent could pressure BSLK's share price, impacting existing investors. For employees, the strategic pivot to focus solely on the Vegan Silk Technology Platform signals a concentrated effort to achieve profitability, but also a narrowing of product development. Customers and the broader market will watch if Bolt's biomaterials can truly disrupt the beauty and personal care industry, competing against established silicone elastomers.

Risk Assessment

Risk Level: high — The risk level is high due to Bolt's history of net losses, including $65.4 million in 2024 and $10.5 million in H1 2025, and an accumulated deficit of $472.3 million as of June 30, 2025. The filing explicitly states, "Our history of losses and negative cash flows from operations and the need for substantial capital raise substantial doubt about our ability to continue as a going concern." Additionally, the company faces potential Nasdaq delisting if its appeal is unsuccessful, which would severely impact liquidity.

Analyst Insight

Investors should exercise extreme caution and consider avoiding BSLKW given the significant financial distress, including substantial losses and an accumulated deficit of $472.3 million. The $20.0 million equity line provides some capital, but the potential for continuous dilution from Ascent's resale of up to 20,085,588 shares, coupled with the risk of Nasdaq delisting, presents a highly speculative investment.

Key Numbers

• $20.0 million — Maximum aggregate gross proceeds from ELOC (Amount Bolt Projects Holdings, Inc. may receive from selling common stock to Ascent Partners Fund LLC)
• 20,085,588 — Total shares registered for resale by Selling Stockholder (Includes Purchase Shares and Commitment Shares for potential market sale)
• $65.4 million — Net loss for year ended December 31, 2024 (Indicates significant financial losses for Bolt Projects Holdings, Inc.)
• $10.5 million — Net loss for six months ended June 30, 2025 (Continual financial losses for Bolt Projects Holdings, Inc.)
• $472.3 million — Accumulated deficit as of June 30, 2025 (Reflects substantial historical losses for Bolt Projects Holdings, Inc.)
• $3.96 — Closing price of common stock on September 25, 2025 (Current market valuation of BSLK shares)
• $1.00 — Floor Price for ELOC purchases (Minimum volume weighted average price for Ascent to be obligated to purchase shares)
• 9.99% — Beneficial ownership limit for Selling Stockholder (Maximum voting power Ascent Partners Fund LLC can hold)
• 80 — Granted patents (Part of the intellectual property portfolio for Vegan Silk Technology Platform)
• 116 — Pending patent applications (Part of the intellectual property portfolio for Vegan Silk Technology Platform)

Key Players & Entities

• Bolt Projects Holdings, Inc. (company) — Registrant and issuer of securities
• Ascent Partners Fund LLC (company) — Selling Stockholder and provider of Equity Line of Credit
• Daniel Widmaier (person) — Chief Executive Officer of Bolt Projects Holdings, Inc.
• Drew Capurro (person) — Legal counsel from Latham & Watkins LLP
• Nasdaq Global Market (regulator) — Stock exchange where BSLK is listed
• Securities and Exchange Commission (regulator) — Regulatory body for S-1 filing
• Golden Arrow Merger Corp. (company) — Former name of the registrant
• Bolt Threads, Inc. (company) — Wholly-owned subsidiary after Business Combination

FAQ

Risk Factors

• History of Significant Losses and Accumulated Deficit [high — financial]: Bolt Projects Holdings, Inc. has a substantial history of financial losses, reporting a net loss of $65.4 million for the year ended December 31, 2024, and $10.5 million for the six months ended June 30, 2025. As of June 30, 2025, the company had an accumulated deficit of $472.3 million. This ongoing financial underperformance raises concerns about the company's ability to achieve profitability and sustain its operations.
• Reliance on Equity Line of Credit (ELOC) [high — financial]: The company's ability to raise capital is heavily reliant on an Equity Line of Credit (ELOC) facility with Ascent Partners Fund LLC, allowing Bolt to sell up to $20.0 million of common stock. The ELOC has a floor price of $1.00, which could lead to significant dilution for existing shareholders if the stock price falls below this level. The company will not receive proceeds from Ascent's resale of shares, only from direct sales under the ELOC.
• Potential Nasdaq Delisting [high — regulatory]: Bolt Projects Holdings, Inc. faces the risk of being delisted from the Nasdaq stock exchange. The company is currently undergoing an appeal process to maintain its listing. Failure to regain compliance or a successful delisting would significantly impact the liquidity and marketability of its common stock.
• Concentration on Vegan Silk Technology [medium — operational]: The company has strategically shifted its focus solely to its Vegan Silk Technology Platform, discontinuing other product candidates in early 2023. This concentration means the success of the company is now entirely dependent on the market acceptance and commercial viability of this single technology platform.
• Limited Trading Volume and Liquidity [medium — market]: The common stock trades on Nasdaq under 'BSLK', closing at $3.96 per share on September 25, 2025. While registered, the actual trading volume and liquidity of the shares, especially considering the potential resale of 20,085,588 shares, could be impacted by market demand and the overall financial health of the company.

Industry Context

Bolt Projects Holdings, Inc. operates in the materials science and sustainable technology sector, specifically focusing on alternatives to traditional materials. The market for sustainable and vegan alternatives is growing, driven by increasing consumer awareness and regulatory pressures. However, this sector is also competitive, with established players and emerging innovators vying for market share. The success of Bolt's Vegan Silk Technology Platform will depend on its ability to differentiate itself on performance, cost, and scalability compared to both conventional materials and other sustainable alternatives.

Regulatory Implications

The company's S-1 filing is a standard requirement for registering securities for resale. A key regulatory risk is the potential delisting from Nasdaq, which would impact liquidity. Compliance with SEC reporting requirements is critical. Furthermore, any claims or representations made about the 'Vegan Silk Technology' will be subject to scrutiny by regulatory bodies like the FTC regarding truthfulness and substantiation.

What Investors Should Do

1. Evaluate the long-term viability of the Vegan Silk Technology Platform.
2. Analyze the dilution risk associated with the ELOC.
3. Monitor the Nasdaq delisting appeal status.
4. Assess the company's cash burn rate and runway.

Key Dates

• 2023-01-01: Discontinuation of other product candidates — Signaled a strategic pivot to focus solely on the Vegan Silk Technology Platform, concentrating all future development and commercialization efforts.
• 2024-12-31: Year-end financial reporting — Reported a net loss of $65.4 million, highlighting significant ongoing financial challenges.
• 2025-06-30: Mid-year financial reporting — Reported a net loss of $10.5 million and an accumulated deficit of $472.3 million, underscoring persistent financial difficulties.
• 2025-09-25: Common stock closing price — The stock closed at $3.96, providing a current market valuation snapshot for investors.
• 2025-09-26: S-1 Filing — Registered up to 20,085,588 shares for resale by Ascent Partners Fund LLC, detailing the terms of the ELOC and commitment shares.

Glossary

Equity Line of Credit (ELOC)

A financing arrangement where a company can sell shares of its common stock to an investor at its discretion, up to a pre-determined limit and subject to certain conditions, like a floor price. (This is Bolt's primary mechanism for potentially raising up to $20.0 million, but it carries risks of dilution and depends on the investor's commitment.)

Purchase Shares

Shares of common stock that Bolt Projects Holdings, Inc. can sell to Ascent Partners Fund LLC under the ELOC facility. (These are the shares that will be sold to Ascent to provide capital to Bolt, up to a maximum of 20,000,000 shares.)

Commitment Shares

Shares issued to an investor as compensation for their commitment to a financing facility, such as an ELOC. (Ascent Partners Fund LLC receives 85,588 commitment shares for its agreement to the ELOC, which are registered for resale.)

Accumulated Deficit

The total cumulative net losses of a company since its inception that have not been offset by profits. (Bolt's substantial accumulated deficit of $472.3 million as of June 30, 2025, indicates a long history of unprofitability.)

Floor Price

The minimum price at which an investor is obligated to purchase shares under a financing agreement like an ELOC. (The $1.00 floor price for Bolt's ELOC means that if the market price falls below this, Ascent is still obligated to buy at $1.00, potentially causing significant dilution to existing shareholders.)

Vegan Silk Technology Platform

Bolt's core business focus, involving the development and commercialization of a sustainable, plant-based alternative to traditional silk. (The company's future success is entirely dependent on the market adoption and profitability of this technology.)

Year-Over-Year Comparison

This S-1 filing represents a significant shift from previous filings, primarily due to the company's strategic pivot to focus exclusively on its Vegan Silk Technology Platform. While specific comparative financial data from a prior S-1 is not detailed here, the current filing highlights a substantial accumulated deficit of $472.3 million as of June 30, 2025, and recent net losses of $65.4 million (FY2024) and $10.5 million (H1 2025), indicating a continued struggle for profitability. A new key risk factor introduced is the reliance on the Equity Line of Credit (ELOC) with Ascent Partners Fund LLC for future capital, alongside the ongoing threat of Nasdaq delisting.

Key Financial Figures

• $0.0001 — 8 shares of our common stock, par value $0.0001 per share ("common stock"), consisting
• $20.0 million — ckholder. However, we may receive up to $20.0 million in aggregate gross proceeds from the Se
• $3.96 — e closing price of our common stock was $3.96 per share. We are an "emerging growth
• $300 million — n 13 years of development and more than $300 million invested in research and product develo
• $65.4 million — of net losses, including a net loss of $65.4 million for the year ended December 31, 2024 an
• $10.5 million — or the year ended December 31, 2024 and $10.5 million for the six months ended June 30, 2025.
• $472.3 million — e 30, 2025, our accumulated deficit was $472.3 million. Moving forward, we are committed to d
• $1.00 — in the Purchase Agreement) is less than $1.00 (the "Floor Price"). Pursuant to the P
• $25,000 — a trading day and the amount is between $25,000 and $500,000, the price will be 96% of
• $500,000 — y and the amount is between $25,000 and $500,000, the price will be 96% of the lowest vo
• $5.0 million — rice, the notice amount must not exceed $5.0 million. In this case, the Share Price will be

Filing Documents

• ea0258133-s1_bolt.htm (S-1) — 2873KB
• ea025813301ex5-1_bolt.htm (EX-5.1) — 14KB
• ea025813301ex23-1_bolt.htm (EX-23.1) — 2KB
• ea025813301ex-fee_bolt.htm (EX-FILING FEES) — 13KB
• image_001.jpg (GRAPHIC) — 148KB
• ex5-1_001.jpg (GRAPHIC) — 2KB
• ex5-1_002.jpg (GRAPHIC) — 2KB
• 0001213900-25-092437.txt ( ) — 14312KB
• bslk-20250630.xsd (EX-101.SCH) — 132KB
• bslk-20250630_cal.xml (EX-101.CAL) — 77KB
• bslk-20250630_def.xml (EX-101.DEF) — 701KB
• bslk-20250630_lab.xml (EX-101.LAB) — 1107KB
• bslk-20250630_pre.xml (EX-101.PRE) — 722KB
• ea0258133-s1_bolt_htm.xml (XML) — 1888KB
• ea025813301ex-fee_bolt_htm.xml (XML) — 5KB

RISK FACTORS

RISK FACTORS 7 THE EQUITY LINE OF CREDIT FACILITY 32

USE OF PROCEEDS

USE OF PROCEEDS 36 DIVIDEND POLICY 37

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 38

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 68 BENEFICIAL OWNERSHIP 71 SELLING STOCKHOLDER 73 MANAGEMENT 75 EXECUTIVE AND DIRECTOR COMPENSATION 81 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 89 PLAN OF DISTRIBUTION 92 LEGAL MATTERS 93 EXPERTS 93 WHERE YOU CAN FIND MORE INFORMATION 94 INDEX TO FINANCIAL STATEMENTS F-1 You should rely only on the information contained in this prospectus. No one has been authorized to provide you with information that is different from that contained in this prospectus. This prospectus is dated as of the date set forth on the cover hereof. You should not assume that the information contained in this prospectus is accurate as of any date other than that date. For investors outside the United States: We have not done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus. i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission (the "SEC") using a "shelf" registration process. Under this shelf registration process, the Selling Stockholder may, from time to time, sell the securities offered by it described in this prospectus. We will not receive any proceeds from the sale by the Selling Stockholder of the securities offered by it described in this prospectus. However, we may receive up to $20.0 million in aggregate gross proceeds from the Selling Stockholder under the Purchase Agreement in connection with sales of our common stock to the Selling Stockholder pursuant to the Purchase Agreement after the date of this prospectus. We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospec

View Full Filing

View this S-1 filing on SEC EDGAR